HPV vaccine 'offers chance' of wiping out cervical cancer in rich countries

Study shows vaccine has greatly reduced infections among girls and young women

Elimination of cervical cancer in wealthy countries such as the UK may be possible within decades, say experts, following a major study showing the success of the HPV jab in protecting women.

Human papilloma virus, which is sexually transmitted, can cause cervical cancer as well as anogenital warts. Data from high-income countries shows vaccination has led to an 83% reduction in HPV infections in 15- to 19-year-old girls over five to eight years. Among women aged 20 to 24, infections are down 66%.